Cargando…

Lung Cancer Organoids as Avatars of Patients With Lung Cancer in the Prediction of Therapeutic Response

Detalles Bibliográficos
Autores principales:	Rosell, Rafael, Pedraz-Valdunciel, Carlos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10568265/ https://www.ncbi.nlm.nih.gov/pubmed/37842325 http://dx.doi.org/10.1016/j.jtocrr.2023.100571

Ejemplares similares

Osimertinib and pterostilbene in EGFR-mutation-positive non-small cell lung cancer (NSCLC)
por: Bracht, Jillian Wilhelmina Paulina, et al.
Publicado: (2019)

Coregulation of pathways in lung cancer patients with EGFR mutation: therapeutic opportunities
por: Rosell, Rafael, et al.
Publicado: (2021)

Urological cancer organoids, patients' avatars for precision medicine: past, present and future
por: Chen, Haotian, et al.
Publicado: (2022)

Patient-derived organoids as personalized avatars and a potential immunotherapy model in cervical cancer
por: Huang, Hua, et al.
Publicado: (2023)

Science and biology drives the immune system to cure lung cancer patients: a revolution but not without challenges
por: Karachaliou, Niki, et al.
Publicado: (2018)

Combinatorial Blood Platelets-Derived circRNA and mRNA Signature for Early-Stage Lung Cancer Detection
por: D’Ambrosi, Silvia, et al.
Publicado: (2023)

Keynote 407: the combination of pembrolizumab and chemotherapy cracks the shell of squamous cell lung cancer
por: Viteri, Santiago, et al.
Publicado: (2020)

Patient-derived lung cancer organoids as in vitro cancer models for therapeutic screening
por: Kim, Minsuh, et al.
Publicado: (2019)

Assays for predicting and monitoring responses to lung cancer immunotherapy
por: Teixidó, Cristina, et al.
Publicado: (2015)

Insights into EGFR Mutations and Oncogenic KRAS Mutations in Non-Small-Cell Lung Cancer
por: Rosell, Rafael, et al.
Publicado: (2023)

Digital multiplexed analysis of circular RNAs in FFPE and fresh non‐small cell lung cancer specimens
por: Pedraz‐Valdunciel, Carlos, et al.
Publicado: (2022)

Multiplex Analysis of CircRNAs from Plasma Extracellular Vesicle-Enriched Samples for the Detection of Early-Stage Non-Small Cell Lung Cancer
por: Pedraz-Valdunciel, Carlos, et al.
Publicado: (2022)

Erratum to Assays for predicting and monitoring responses to lung cancer immunotherapy
por: Teixidó, Cristina, et al.
Publicado: (2015)

Organoids in Lung Cancer Management
por: Li, Yushi, et al.
Publicado: (2021)

A New Mouse Avatar Model of Non-Small Cell Lung Cancer
por: Russo, Maria Veronica, et al.
Publicado: (2015)

Personalized cancer avatars for patients with thymic malignancies: A pilot study with circulating tumor cell‐derived organoids
por: Wu, Yuan‐Hung, et al.
Publicado: (2023)

Mitochondrial avatars for quantitative aging research
por: Hoffman, Timothy E., et al.
Publicado: (2018)

Proprotein convertase furin in SARS-CoV-2 and non-small cell lung cancer
por: Rosell, Rafael, et al.
Publicado: (2020)

New avatars in endocrine practice: The bariatric physician
por: John, Mathew, et al.
Publicado: (2013)

New Therapeutic Strategies for Lung Cancer
por: Icard, Philippe, et al.
Publicado: (2021)

Analysis of extracellular vesicle mRNA derived from plasma using the nCounter platform
por: Bracht, Jillian W. P., et al.
Publicado: (2021)

Lung cancer organoids analyzed on microwell arrays predict drug responses of patients within a week
por: Hu, Yawei, et al.
Publicado: (2021)

The application of patient-derived organoid in the research of lung cancer
por: Li, Yin, et al.
Publicado: (2023)

Molecular markers as therapeutic targets in lung cancer
por: Tseng, Hsin-Hui, et al.
Publicado: (2013)

Gene Expression Signatures Predicting Survival and Chemotherapy Benefit in Patients with Resected Non-small-Cell Lung Cancer
por: Rosell, Rafael, et al.
Publicado: (2018)

Acquired BRAF gene fusions in Osimertinib resistant EGFR-mutant non-small cell lung cancer
por: Rosell, Rafael, et al.
Publicado: (2023)

Avatar
Publicado: (2010)

Diagnostic and Predictive Biomarkers in Lung Cancer
por: Fumagalli, Caterina, et al.
Publicado: (2021)

Patient-derived organoids and orthotopic xenografts of primary and recurrent gliomas represent relevant patient avatars for precision oncology
por: Golebiewska, Anna, et al.
Publicado: (2020)

STAT3 as a potential immunotherapy biomarker in oncogene-addicted non-small cell lung cancer
por: Attili, Ilaria, et al.
Publicado: (2018)

Ablating lung cancer, knowing the tumor better
por: Rosell, Rafael, et al.
Publicado: (2022)

Standard: Human intestinal cancer organoids
por: Lin, Hanqing, et al.
Publicado: (2023)

Organoid culture of bladder cancer cells
por: Yoshida, Takahiro, et al.
Publicado: (2018)

Predictive Biomarkers of Response to Src Inhibitors in Lung Cancer. Getting to YES1
por: Li, Howard Y., et al.
Publicado: (2019)

Genomic characteristics and drug screening among organoids derived from non‐small cell lung cancer patients
por: Chen, Jing‐Hua, et al.
Publicado: (2020)

Avatar : novela /
por: Gautier, Théophile, 1811-1872
Publicado: (1921)

Avatar-Based Strategies for Breast Cancer Patients: A Systematic Review
por: Rodríguez-Guidonet, Irene, et al.
Publicado: (2023)

Patient-derived organoids of lung cancer based on organoids-on-a-chip: enhancing clinical and translational applications
por: Zeng, Xiao, et al.
Publicado: (2023)

Obesity paradox and lung cancer, metformin-based therapeutic opportunity?
por: Barrios-Bernal, Pedro, et al.
Publicado: (2023)

Moving toward precision medicine with lung cancer organoids
por: Kim, James, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_h871ef9i185d6occtr1vd3u4gg